boss phil
Former Florida Congressman Matt Gaetz has removed himself from consideration for the next US attorney general, saying his confirmation fight had become a “distraction” to President-elect Donald Trump. Trump had announced Gaetz as his choice last week, calling him the best candidate to “restore Americans’ badly-shattered faith and confidence” in the Department of Justice, accused of political persecutions of Republicans. “While the momentum was strong, it is clear that my confirmation was unfairly becoming a distraction to the critical work of the Trump/Vance Transition. There is no time to waste on a needlessly protracted Washington scuffle, thus I’ll be withdrawing my name from consideration,” Gaetz posted on X on Thursday. “I remain fully committed to see that Donald J. Trump is the most successful president in history.” Under US law, a president’s cabinet picks need to be approved by the Senate. Gaetz faced the opposition of all the Democrats but also a few Republicans who have signaled they would oppose Trump’s agenda come January. Mitch McConnell of Kentucky, Susan Collins of Maine, Lisa Murkowski of Alaska and John Curtis of Utah – Mitt Romney’s replacement – were reportedly against approving Gaetz, drawing the ire of many Republicans who pointed out that most of them voted for current AG Merrick Garland, thereby enabling his alleged abuses of office. In a post on Truth Social, Trump said he greatly appreciated Gaetz’s efforts to get confirmed. “Matt has a wonderful future, and I look forward to watching all of the great things he will do!” the president-elect said. Gaetz “made his decision to withdraw entirely out of respect for President Trump’s administration,” said Vice President-elect JD Vance. “Matt is a patriot and I look forward to seeing what he does next.” Democrats, rebel Republicans and many media outlets joined forces against Gaetz, denouncing him for alleged sexual dalliances with underage women. The Florida congressman had conclusively debunked the allegations, and the DOJ dropped the investigation last year without ever pressing charges. The House Ethics Committee kept them alive, however, reportedly thanks to California Congressman Kevin McCarthy, whose ouster from the speaker’s chair last year was spear-headed by Gaetz. “Years-old allegations of a sexual / salacious nature from sources DOJ previously deemed not credible assembled by people with a political motive. The Steele Dossier really was shameful,” Gaetz had posted just two hours prior to his surprise withdrawal. The ‘Steele Dossier’ was the fabricated set of claims about Trump the Democrats commissioned from a British spy in 2016. The dossier was the key piece of their ‘Russiagate’ conspiracy theory used to undermine Trump’s first presidential term, and was even cited by the FBI to spy on the Republican’s campaign and administration.Analysts' ratings for Bruker BRKR over the last quarter vary from bullish to bearish, as provided by 7 analysts. The following table summarizes their recent ratings, shedding light on the changing sentiments within the past 30 days and comparing them to the preceding months. Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 1 3 3 0 0 Last 30D 0 0 1 0 0 1M Ago 0 0 1 0 0 2M Ago 1 3 1 0 0 3M Ago 0 0 0 0 0 The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $70.0, a high estimate of $75.00, and a low estimate of $60.00. Highlighting a 10.06% decrease, the current average has fallen from the previous average price target of $77.83. Breaking Down Analyst Ratings: A Detailed Examination An in-depth analysis of recent analyst actions unveils how financial experts perceive Bruker. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets. Analyst Analyst Firm Action Taken Rating Current Price Target Prior Price Target Dan Leonard UBS Lowers Neutral $66.00 $102.00 Matthew Sykes Goldman Sachs Maintains Neutral $60.00 $60.00 Patrick Donnelly Citigroup Lowers Buy $75.00 $80.00 Dan Brennan TD Cowen Lowers Hold $70.00 $72.00 Brandon Couillard Wells Fargo Lowers Overweight $75.00 $78.00 Terence Malone Barclays Lowers Overweight $69.00 $75.00 Terence Malone Barclays Announces Overweight $75.00 - Key Insights: Action Taken: Analysts adapt their recommendations to changing market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their response to recent developments related to Bruker. This information provides a snapshot of how analysts perceive the current state of the company. Rating: Offering a comprehensive view, analysts assess stocks qualitatively, spanning from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Bruker compared to the broader market. Price Targets: Understanding forecasts, analysts offer estimates for Bruker's future value. Examining the current and prior targets provides insight into analysts' changing expectations. Considering these analyst evaluations in conjunction with other financial indicators can offer a comprehensive understanding of Bruker's market position. Stay informed and make well-informed decisions with our Ratings Table. Stay up to date on Bruker analyst ratings. Unveiling the Story Behind Bruker Bruker Corp manufactures scientific instruments and diagnostic tests for customers in the life sciences, pharmaceutical, and biotechnology industries. It operates in four operating segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy and Supercon Technologies (BEST). The company generates maximum revenue from the BSI CALID segment. Geographically, it derives the maximum of its revenue from Asia Pacific. A Deep Dive into Bruker's Financials Market Capitalization: Indicating a reduced size compared to industry averages, the company's market capitalization poses unique challenges. Revenue Growth: Over the 3 months period, Bruker showcased positive performance, achieving a revenue growth rate of 16.37% as of 30 September, 2024. This reflects a substantial increase in the company's top-line earnings. When compared to others in the Health Care sector, the company excelled with a growth rate higher than the average among peers. Net Margin: Bruker's net margin is below industry averages, indicating potential challenges in maintaining strong profitability. With a net margin of 4.73%, the company may face hurdles in effective cost management. Return on Equity (ROE): The company's ROE is a standout performer, exceeding industry averages. With an impressive ROE of 2.27%, the company showcases effective utilization of equity capital. Return on Assets (ROA): Bruker's ROA lags behind industry averages, suggesting challenges in maximizing returns from its assets. With an ROA of 0.68%, the company may face hurdles in achieving optimal financial performance. Debt Management: Bruker's debt-to-equity ratio surpasses industry norms, standing at 1.34 . This suggests the company carries a substantial amount of debt, posing potential financial challenges. Analyst Ratings: What Are They? Experts in banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their comprehensive research involves attending company conference calls and meetings, analyzing financial statements, and engaging with insiders to generate what are known as analyst ratings for stocks. Typically, analysts assess and rate each stock once per quarter. Analysts may supplement their ratings with predictions for metrics like growth estimates, earnings, and revenue, offering investors a more comprehensive outlook. However, investors should be mindful that analysts, like any human, can have subjective perspectives influencing their forecasts. Breaking: Wall Street's Next Big Mover Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. Click here for urgent details . This article was generated by Benzinga's automated content engine and reviewed by an editor. © 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Several wounded N.Korean soldiers died after being captured by Ukraine: ZelenskyEditor’s note: The views expressed in this commentary are solely those of the writer. CNN is showcasing the work of The Conversation , a collaboration between journalists and academics to provide news analysis and commentary. The content is produced solely by The Conversation. The Ebola virus devastated west Africa in 2014, claiming over 11,000 lives in Sierra Leone, Liberia and Guinea. It was the largest Ebola outbreak since the virus had first been discovered in the Democratic Republic of Congo in 1976 . Ebola is a terrifying virus which, if left untreated, causes bleeding inside the body and through the eyes, nose, mouth and rectum. Case fatality rates have varied from 25% to 90% in past outbreaks , depending on circumstances and the response. The 2014 outbreak in west Africa exposed a critical gap in global preparedness for infectious diseases: the absence of effective vaccines. There were no drugs or vaccines approved to treat or prevent Ebola or ready to enter into clinical trials at the outset of the epidemic. Therefore, many felt it was ethically necessary to conduct such research as quickly and safely as possible. As a biologist and epidemiologist, I travelled to Guinea amid the chaos to coordinate the laboratory activities of the rVSV-ZEBOV Ebola vaccine trials . Almost 10,000 participants were enrolled in trials to make sure the drug was safe and effective to use. The trials would last two years and involved more than 500 scientists and healthcare workers. My five-year-old daughter, Ashanti, spoke words that strengthened my resolve: “People need you to support them. If you don’t go, who will?” READ MORE: Mpox vaccines: where they come from and what stands in the way of distributing them in Africa Her encouragement fuelled me as I led the trial’s laboratory operations, navigating immense logistical and emotional challenges. We had to set up a full laboratory in a week, to process thousands of samples. Delivering the vaccine required ultra cold freezers (minus 80°C) ; none were available in the country. We had to address vaccine hesitancy among the population of Guinea, including the medical and academic community. Of course there was also fear of getting infected by a disease that was a virtual death sentence. First line workers and individuals in close contact with confirmed Ebola cases were vaccinated with rVSV-ZEBOV. This created a protective “ring” around the infected. As a field coordinator, I witnessed firsthand the challenges of conducting research into the safety of the vaccine in the middle of an outbreak. Collaboration between the World Health Organization , Médecins Sans Frontières , the medical research centre Epicentre and local health authorities proved pivotal. These efforts also underscored the importance of adaptable, rapid-response research during health crises. READ MORE: 154 million lives saved in 50 years: 5 charts on the global success of vaccines On 18 August 2015 the preliminary results of the trial were announced. They marked a turning point in the fight against Ebola. The vaccine’s near-perfect efficacy offered a rare moment of hope. Today Sierra Leone is embarking on a nationwide campaign with the rVSV-ZEBOV vaccine, trademarked as Ervebo . The campaign will target 20,000 frontline workers in 16 districts. These include healthcare workers, traditional healers, community health and social workers, laboratory personnel, motorcycle taxi drivers and security forces. Anybody who will be involved in any response to future outbreaks. How does Ervebo work? The Ervebo vaccine, developed by Merck , is a single-dose vaccine. It works by using a modified virus to produce antibodies against Ebola, equipping the immune system to recognise and neutralise the virus upon exposure. Clinical trials have shown its efficacy exceeds 95% in preventing infection from the Zaire Ebola virus strain , the deadliest variant. The vaccine was deployed during the 2018-2020 Ebola epidemic in the Democratic Republic of Congo under emergency use authorisation . This allows a medical product to be used without being authorised by the relevant drug agencies, such the Food and Drug Administration in the United States, the European Medicines Agency and the African Medicines Agency . It was also used in Burundi , Uganda, South Sudan and Rwanda in preventive vaccination campaigns to protect healthcare and frontline workers. Ervebo is now a cornerstone in the fight against Ebola, particularly in controlling outbreaks caused by the Zaire strain. However, its success depends on ensuring equitable access and strengthening healthcare systems. What are the challenges? Challenges do persist, including limited vaccine supply, logistical hurdles in remote regions, and vaccine hesitancy fuelled by misinformation. READ MORE: Vaccine misinformation distorts science – a biochemist explains how RFK Jr. and his lawyer’s claims threaten public health Addressing these obstacles requires coordinated efforts between governments, health organisations and communities. Additionally, establishing local vaccine manufacturing in Africa should be a long-term goal, giving affected countries greater control over supply and distribution. Could the vaccine bring an end to Ebola? While Ervebo is a monumental achievement, it cannot end Ebola on its own. The virus’s ability to persist in animal reservoirs such as bats and to then be transmitted to humans means that vaccination must be part of a broader strategy. Integrating vaccination, surveillance, outbreak response and community engagement is essential for achieving long-term control. Ervebo’s success provides a model for addressing other infectious disease outbreaks, like mpox. Clinical trials during the mpox outbreak could potentially lead to new and effective vaccines.TORONTO — When Geoffrey Hinton strode across the Stockholm Concert Hall stage Tuesday to receive his Nobel Prize for physics from King Carl XVI Gustaf of Sweden, he was beaming. It has taken decades for many beyond the science community to realize the British Canadian computer scientist's life's work was so significant it eventually formed the foundation of artificial intelligence. But on Tuesday, as he accepted the Nobel diploma and its accompanying gold medal with co-laureate John Hopfield, there was no question about the importance of Hinton's discoveries nor how he has shaped history. Instead, there was only pride for the affable 77-year-old, often called the godfather of AI — and that pride stretched from Stockholm to Toronto. A crowd of about 100 students and colleagues at the University of Toronto, where Hinton is a professor emeritus, gathered at the school's downtown campus to watch the Nobel ceremony. Two other watch parties took over the school's Mississauga and Scarborough campuses. Any mention of physics or a sighting of Hinton, clad in a dark suit and white bow tie, generated rousing applause at the Toronto gathering. When the man of the hour headed to retrieve his accolade from the King, a few former students and colleagues wiped tears from their eyes. "There is, at least for me, this sense that Prof. Hinton created the whole ecosystem here, where there are thousands of people who are working on his ideas," Michael Guerzhoy, one of Hinton's former students who went on to teach a course Hinton had once led at the university, said before the ceremony began. The idea that earned Hinton the Nobel dates back to the 1980s, when he was working at Carnegie Mellon University in Pittsburgh and AI was far from the buzzy technology it is today. It was then that Hinton developed the Boltzmann machine, which learns from examples, rather than instructions, and when trained, can recognize familiar characteristics in information, even if it has not seen that data before. "It was a lot of fun doing the research but it was slightly annoying that many people — in fact, most people in the field of AI — said that neural networks would never work," Hinton recalled during a press conference on the October day he was named as a Nobel laureate. "They were very confident that these things were just a waste of time and we would never be able to learn complicated things like, for example, understanding natural language using neural networks — and they were wrong." Neural networks are computational models that resemble the human brain's structure and functions. When Nobel physics committee chair Ellen Moons presented Hinton to receive his award, she said these networks are good at sorting and interpreting large amounts of data and self-improve based on the accuracy of the results they generate. "Today, artificial neural networks are powerful tools in research fields spanning physics, chemistry and medicine, as well as in daily life," she said. John DiMarco wasn't surprised that Hinton's work paved the way for such possibilities, but the IT director for U of T's computer science department was taken aback that Hinton's Nobel came in the unlikely physics category. DiMarco met Hinton roughly 35 years ago in a job interview and quickly took note of his proclivity for humour and the quirks in how his mind works. "He is quite insightful and he goes straight to the core of things," DiMarco said. "He would sometimes come out of his office and share some new idea. We didn't always understand what he was sharing, but he was very excited about it." Many of those ideas required lots of computing power the school's systems didn't have, so DiMarco's team patched together a solution with graphics processing units from video game consoles. DiMarco brought one of Hinton's GPUs to the watch party, which was also attended by Joseph Jay Williams, the director of U of T's Intelligent Adaptive Interventions Lab. Williams took one of Hinton's classes and said the Nobel winner "changed the course of my life" by encouraging him to go to grad school, which then led him to win the XPRIZE Digital Learning Challenge, a global competition aimed at rewarding people who modernize learning tools and processes. Other notable mentees and alumni of Hinton's classes include OpenAI co-founder Ilya Sutskever and Cohere co-founders Nick Frosst and Aidan Gomez. With his Nobel win and so many esteemed protege, Williams said Hinton has become a "reluctant celebrity" who is hounded for photos every time he's on campus. Hinton, however, has taken a much more humble approach to his recent win, which he learned of on a trip to California. He initially thought the call from the academy that gives out the Nobel was "a spoof," but later realized it had to be real because it was placed from Sweden and the speaker had a "strong Swedish accent." The award the academy gave him comes with 11 million Swedish kronor (about $1.4 million) from a bequest arranged by Swedish inventor Alfred Nobel. Hinton and Hopfield will split the money, with some of Hinton's share going to Water First, an Ontario organization working to boost Indigenous access to water, and another unnamed charity supporting neurodiverse young adults. Hinton has said he doesn't plan to do much more "frontier research." "I believe I'm going to spend my time advocating for people to work on safety," he said in October. Last year, Hinton left a role he held at Google to more freely speak about the dangers of AI, which he has said include bias and discrimination, fake news, joblessness, lethal autonomous weapons and even the end of humanity. At a Stockholm press conference over the weekend, he said he doesn’t regret the work he did to lay the foundations of artificial intelligence, but wishes he thought of safety sooner. “In the same circumstances, I would do the same again,” he said. This report by The Canadian Press was first published Dec. 10, 2024. Tara Deschamps, The Canadian Press
By Shariq Khan NEW YORK (Reuters) – Oil prices rose on Friday and were set for a weekly gain in low trading volume ahead of year-end, buoyed by a larger-than-expected drawdown from U.S. crude inventories last week. Brent crude futures rose 91 cents, or 1.2%, to $74.17 per barrel by 1:58 p.m. EST (1858 GMT). U.S. West Texas Intermediate crude futures rose $1.01, or 1.5%, to $70.63 per barrel. On a weekly basis, both Brent and WTI crude are set to gain about 1.6%. U.S. crude oil inventories fell by 4.2 million barrels in the week ended Dec. 20 as refiners ramped up activity and the holiday season boosted fuel demand, data from the U.S. Energy Information Administration showed on Friday. [EIA/S] Analysts polled by Reuters had expected a 1.9 million-barrel drawdown, whereas figures from the American Petroleum Institute released earlier in the week estimated a 3.2 million-barrel draw, according to market sources. [API/S] Optimism over Chinese economic growth has also sparked hopes of higher demand next year from the top oil importing nation. The World Bank on Thursday raised its forecast for Chinese economic growth in 2024 and 2025. Meanwhile, Chinese authorities have agreed to issue special treasury bonds worth 3 trillion yuan ($411 billion) next year, sources told Reuters this week, as Beijing acts to revive the sluggish economy. The war between Russia and Ukraine, which had become an afterthought in energy markets due to stagnant global oil demand, seems to be returning to the forefront after numerous events this week that could impact supplies next year, fuel distributor TACenergy’s trading desk wrote on Friday. NATO said on Friday it would boost its presence in the Baltic Sea, a day after Finland seized a ship carrying Russian oil on suspicion of causing internet and power cable outages. Meanwhile, Dutch and British wholesale natural gas prices rose amid fading hopes for a new deal to transit Russian gas through Ukraine. Tensions have flared in the Middle East too, after Israel raided a north Gaza hospital on Friday and struck targets linked to the Houthi movement in Yemen on Thursday, but these events are unlikely to effect oil prices much heading into next year, StoneX analyst Alex Hodes said. Instead, the largest risk in the Middle East is from sanctions enforcement that will likely occur with the incoming Donald Trump administration in the U.S., he said. (Reporting by Shariq Khan, Alex Lawler, Enes Tunagur and Sudarshan Varadhan; editing by Rod Nickel, Chizu Nomiyama and Chris Reese) Disclaimer: This report is auto generated from the Reuters news service. ThePrint holds no responsibility for its content. var ytflag = 0;var myListener = function() {document.removeEventListener('mousemove', myListener, false);lazyloadmyframes();};document.addEventListener('mousemove', myListener, false);window.addEventListener('scroll', function() {if (ytflag == 0) {lazyloadmyframes();ytflag = 1;}});function lazyloadmyframes() {var ytv = document.getElementsByClassName("klazyiframe");for (var i = 0; i < ytv.length; i++) {ytv[i].src = ytv[i].getAttribute('data-src');}} Save my name, email, and website in this browser for the next time I comment. Δ document.getElementById( "ak_js_1" ).setAttribute( "value", ( new Date() ).getTime() );
Batherson has 3 goals and an assist as Senators beat Ducks 5-1
LAS VEGAS (AP) — A team that previously boycotted at least one match against the San Jose State women's volleyball program will again be faced with the decision whether to play the school , this time in the Mountain West Conference semifinals with a shot at the NCAA Tournament on the line. Five schools forfeited matches in the regular season against San Jose State, which carried a No. 2 seed into the conference tournament in Las Vegas. Among those schools: No. 3 Utah State and No. 6 Boise State, who will face off Wednesday with the winner scheduled to play the Spartans in the semifinals on Friday. Wyoming, Nevada and Southern Utah — which is not a Mountain West member — also canceled regular-season matches, all without explicitly saying why they were forfeiting. Nevada players cited fairness in women’s sports as a reason to boycott their match, while political figures from Wyoming, Idaho, Utah and Nevada suggested the cancellations center around protecting women’s sports. In a lawsuit filed against the NCAA , plaintiffs cited unspecified reports asserting there was a transgender player on the San Jose State volleyball team, even naming her. While some media have reported those and other details, neither San Jose State nor the forfeiting teams have confirmed the school has a trans women’s volleyball player. The Associated Press is withholding the player’s name because she has not publicly commented on her gender identity and through school officials has declined an interview request. A judge on Monday rejected a request made by nine current conference players to block the San Jose State player from competing in the tournament on grounds that she is transgender. That ruling was upheld Tuesday by an appeals court. “The team looks forward to starting Mountain West Conference tournament competition on Friday,” San Jose State said in a statement issued after the appeals court decision. “The university maintains an unwavering commitment to the participation, safety and privacy of all students at San Jose State and ensuring they are able to compete in an inclusive, fair and respectful environment.” Chris Kutz, a Boise State athletics spokesman, said in an email the university would not “comment on potential matchups at this time.” Doug Hoffman, an Aggies athletics spokesman, said in an email Utah State is reviewing the court’s order. “Right now, our women’s volleyball program is focused on the game this Wednesday, and we’ll be cheering them on,” Hoffman wrote. San Jose State, which had a first-round bye, would be sent directly to the conference title game if Utah State or Boise State were to forfeit again. If the Spartans make the title game, it's likely the opponent would not forfeit. They would face top-seeded Colorado State, No. 4 Fresno State or No. 5 San Diego State — all teams that played the Spartans this season. The conference champion receives an automatic bid to the NCAA Tournament. AP college sports: https://apnews.com/hub/college-sportsCristian Romero apologised for comments criticising club's owners - Ange PostecoglouNEW YORK (AP) — Wall Street is set to break more records Monday as U.S. stocks rise to add to last week’s gains. The S&P 500 was 0.2% higher, as of 3 p.m. Eastern time, and sitting just below its all-time high set two weeks ago. The Dow Jones Industrial Average added 397 points, or 0.9%, to its own record set on Friday, while the Nasdaq composite was 0.1% higher. Treasury yields also eased in the bond market amid what some analysts called a “Bessent bounce” after President-elect Donald Trump said he wants , a hedge fund manager, to be his Treasury Secretary. Bessent has argued for reducing the U.S. government’s deficit, which is how much more it spends than it takes in through tax and other revenue. Such an approach could soothe that Trump’s policies may lead to a much bigger deficit, which in turn would put upward pressure on Treasury yields. After climbing above 4.44% immediately after Trump’s election, the yield on the 10-year Treasury fell back to 4.26% Monday and down from 4.41% late Friday. That’s a notable move, and lower yields help make it cheaper for all kinds of companies and households to borrow money. They also give a boost to prices for stocks and other investments. That helped stocks of smaller companies lead the way, and the Russell 2000 index of smaller stocks jumped 2%. It’s set to top its all-time high, which was set three years ago. Smaller companies can feel bigger boosts from lower borrowing costs because of the need of many to borrow to grow. The two-year Treasury yield, which more closely tracks the market’s expectations for what the Federal Reserve will do with overnight interest rates, also eased sharply. The Fed began just a couple months ago from a two-decade high, hoping to keep the after bringing high to its 2% target. But immediately after Trump’s victory, traders had reduced bets for how many cuts the Fed may deliver next year. They were worried Trump's preference for lower tax rates and higher spending on the border would balloon the national debt. . A report coming on Wednesday could influence how much the Fed may cut rates. Economists expect it to show that an underlying inflation trend the Fed prefers to use accelerated to 2.8% last month from 2.7% in September. Higher inflation would make the Fed more reluctant to cut rates as deeply or as quickly as it would otherwise. Goldman Sachs economist David Mericle expects that to slow by the end of next year to 2.4%, but he said inflation would be even lower if not for expected tariff increases on imports from China and autos favored by Trump. In the stock market, jumped 19.1% after delivering stronger profit for the latest quarter than analysts expected. The seller of personal care products and home fragrances also raised its financial forecasts for the full year, even though it still sees a “volatile retail environment” and a shorter holiday shopping season this year. Much focus has been on how resilient U.S. shoppers can remain, given high prices across the economy and still-high interest rates. Last week, two major retailers sent mixed messages. after giving a dour forecast for the holiday shopping season. It followed , which gave a much more encouraging outlook. Another big retailer, Macy’s, said Monday its sales for the latest quarter were in line with its expectations, but it will delay the release of its full financial results. It found a and it needs more time to complete its investigation. Macy’s stock fell 2.9%. Among the market's leaders were several companies related to the housing industry. Monday's drop in Treasury yields could translate into easier mortgage rates, which could spur activity for housing. Builders FirstSource, a supplier or building materials, rose 6.2%. Homebuilders, D.R. Horton, PulteGroup and Lennar all rose at least 5.8%. In stock markets abroad, indexes moved modestly across much of Europe after finishing mixed in Asia. In the crypto market, was trading around $96,800 after threatening to hit $100,000 late last week for the first time. AP Business Writer Elaine Kurtenbach contributed.
AUSTIN, Texas, Dec. 10, 2024 /PRNewswire/ -- Qmerit, North America's leading provider of implementation and integration services for EV charging and other energy transition technologies, is announcing a banner year of alliances and launches designed to jumpstart the growth of electrification and electrical services in 2025. With its North American network of more than 24,000 licensed, certified, and highly trained electricians, Qmerit teamed with brands like Ford, GM Energy, Stellantis, Schneider Electric and Dominion Energy Virginia in ushering programs to make EVs more affordable and easier to use. Qmerit also became a certified installer for the Tesla Powershare charging system that's part of the Tesla Cybertruck. "Qmerit is in a unique position to help quarterback America's drive toward greater electrification," said Qmerit Chief Operating Officer Oliver Phillips. "Workforce underpins any initiative to increase electrification – we have a central role to play in catalyzing cross-sector solutions that meet the practical needs of consumers while creating jobs for America." Qmerit's 2024 calendar of accomplishments includes: These achievements build upon previous successes with such marquee brands as Chevrolet, Toyota, Cadillac, BMW, Mercedes-Benz, Enterprise, NAPA, and the Phoenix water and power company SRP. "Qmerit has a strong history of working across the electrification ecosystem to forge consumer-centric solutions that blend complementary skills and services," said Tom Bowen, President of Qmerit Solutions. "We look forward to leveraging our position to help overcome barriers and challenges in driving electrification forward in the New Year." About Qmerit Qmerit is North America's leading provider of implementation solutions for EV charging, electrical services, and other energy transition technologies, simplifying electrification adoption for residential and business markets. Qmerit's value-driven services are delivered through a network of independent Certified Solutions Partners, Certified Installers and company-owned contractors skilled in system implementation and integration. Qmerit partners with top automakers from the U.S., Europe and Asia. It boasts customer experience (NPS) scores, high above the industry average. Qmerit's white paper, Electrification2030 , examines issues pivotal to broad EV adoption and greater home and building electrification by 2030. For more information, visit https://qmerit.com/ , and connect on Twitter , LinkedIn , Facebook , and Instagram . Media Contact: Samantha Graham samantha.graham@qmerit.com View original content to download multimedia: https://www.prnewswire.com/news-releases/qmerits-2024-milestones-open-growth-paths-for-evs-solar-battery-and-electrical-services-302326702.html SOURCE Qmerit Copyright © 2024 PR Newswire Association LLC. All Rights Reserved.NBT Bancorp director Jack Webb sells $500,567 in stockPublished 02:29 IST, December 12th 2024 Russian President Putin Praises Indian Prime Minister Narendra Modi's Vision, His Future-Thinking Leadership and India's Growth at Russia Event New Delhi: Russian President Vladimir Putin lauded Indian Prime Minister Narendra Modi's leadership and vision at a recent event in Russia, highlighting the significant development steps India has taken under his guidance. Noting that he has been in regular engagement with PM Modi, Putin expressed admiration for the Prime Minister’s initiatives such as ‘Make in India’, and hailed his forward-thinking approach to the country’s development. Emphasizing Prime Minister Modi’s dedication to steering India towards a technologically advanced future, Russian President Putin said, "Incidentally, we have regular contacts with Prime Minister Modi, and we speak on these matters. Of course, his initiative, Make in India, is great, but he's also a person who looks into the future, and this is a fact. We always talk about these opportunities with him, and I think you can feel that." The Russian President also praised PM Modi's economic policies while acknowledging India’s impressive growth globally. He said, "The Prime Minister is always trying to nudge India towards this development, towards pursuing high technology, and the results are evident.” “India demonstrates the highest growth rates among developing nations, and this is something to congratulate you on," Putin asserted, highlighting India's success in driving economic expansion and technological innovation. The Russian president’s remarks have come at a time when India is increasingly being recognised for its dynamic growth and strategic focus on high-tech industries. Additionally, the praise from Putin also underscores the growing bilateral strength between Russia and India. Notably, the ‘Make in India’ campaign, launched by Prime Minister Modi in 2014, aims to turn India into a global manufacturing hub, attracting foreign investment and boosting domestic industries. Moreover, the initiative focused on making India, a self-dependent country, eventually increasing the country’s exports globally. Under PM Modi’s leadership, India has made significant progress in several sectors, including technology, infrastructure, and digital innovation, solidifying its position as one of the fastest-growing economies in the world. Get Current Updates on India News , Entertainment News along with Latest News and Top Headlines from India and around the world. Updated 02:29 IST, December 12th 2024